Yüklüyor......
Prophylaxis use among males with haemophilia B in the United States
INTRODUCTION: Prophylaxis is considered the optimal treatment for persons with moderate to severe haemophilia (factor activity between 1–5% of normal and <1% of normal respectively) in countries where safe factor concentrates are available and economically feasible. Historically, prophylactic tre...
Kaydedildi:
| Yayımlandı: | Haemophilia |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5724962/ https://ncbi.nlm.nih.gov/pubmed/28780772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hae.13317 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|